preclinical


Also found in: Thesaurus, Medical, Wikipedia.
Related to preclinical: preclinical phase

pre·clin·i·cal

 (prē-klĭn′ĭ-kəl)
adj.
1. Of or relating to the period of a disease before the appearance of symptoms.
2. Of or relating to research conducted prior to direct experimental treatment or observation of human subjects: preclinical drug trials.
American Heritage® Dictionary of the English Language, Fifth Edition. Copyright © 2016 by Houghton Mifflin Harcourt Publishing Company. Published by Houghton Mifflin Harcourt Publishing Company. All rights reserved.

preclinical

(priːˈklɪnɪkəl)
adj
1. (Medicine) of, relating to, or occurring during the early phases of a disease before accurate diagnosis is possible
2. (Medicine) of, relating to, or designating an early period of scientific study by a medical student before practical experience with patients
preˈclinically adv
Collins English Dictionary – Complete and Unabridged, 12th Edition 2014 © HarperCollins Publishers 1991, 1994, 1998, 2000, 2003, 2006, 2007, 2009, 2011, 2014

pre•clin•i•cal

(priˈklɪn ɪ kəl)

adj.
of or pertaining to the period prior to the appearance of symptoms.
[1930–35]
pre•clin′i•cal•ly, adv.
Random House Kernerman Webster's College Dictionary, © 2010 K Dictionaries Ltd. Copyright 2005, 1997, 1991 by Random House, Inc. All rights reserved.
ThesaurusAntonymsRelated WordsSynonymsLegend:
Adj.1.preclinical - of or relating to the early phases of a disease when accurate diagnosis is not possible because symptoms of the disease have not yet appeared
Based on WordNet 3.0, Farlex clipart collection. © 2003-2012 Princeton University, Farlex Inc.
Translations

preclinical

adj (Med) Studiumvorklinisch
Collins German Dictionary – Complete and Unabridged 7th Edition 2005. © William Collins Sons & Co. Ltd. 1980 © HarperCollins Publishers 1991, 1997, 1999, 2004, 2005, 2007
References in periodicals archive ?
M2 PRESSWIRE-September 5, 2019-: Preclinical CRO 2019 Global Market Outlook,Research,Trends and Forecast to 2024
Amicus Therapeutics (FOLD) has entered into a strategic manufacturing agreement with Paragon Gene Therapy, a unit of Catalent Biologics (CTLT), for clinical manufacturing capabilities and capacity for multiple active preclinical lysosomal disorder programs that are currently in development in collaboration with the University of Pennsylvania.
Dr Hurter will be responsible in moving the company forward from transformative concept to preclinical trials to early drug development.
After the award, CIRM will be a more active partner with its recipients to further increase the likelihood of clinical success and help advance a preclinical applicant's research along a funding pipeline towards clinical trials.
(CBMG) said the California Institute for Regenerative Medicine (CIRM), California's stem cell agency, has awarded the company $2.29 million to support preclinical studies of AlloJoin, an "off-the-shelf allogeneic human adipose-derived mesenchymal stem cells for the treatment of knee osteoarthritis in the U.S.
Lovelace Biomedical has launched operations as a preclinical CRO, offering toxicology, pharmacology and other services to pharma and biopharma companies, from its 300,000 sq.-ft., bio-secure lab facility.
The whole patent portfolio together with key preclinical assets have been transferred.
The National Cancer Institute (NCI), the NIEHS, the National Institute of Biomedical Imaging and Bioengineering (NIBIB), and the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) invite applications for the development and delivery of novel image acquisition or enhancement technology and methods for biomedical imaging and image-guided interventions and therapy, which may incorporate limited pilot or clinical feasibility evaluations using either preclinical models or clinical studies.
M2 PRESSWIRE-August 19, 2019-: Preclinical CRO Market to Display an 8.14% of CAGR till 2024 | PAREXEL International Corporation, IQVIA, Envigo, Charles River, etc
Aptose Biosciences announced that new preclinical data for CG-806, its oral, first-in-class pan-FLT3/pan-BTK inhibitor, is being presented in a poster presentation today at the 24th Congress of the European Hematology Association in Amsterdam, the Netherlands.